ALK Fundamental Analysis - ALKEMY SPA

Fundamental Rating

ALK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 28 industry peers in the Professional Services industry. ALK has a bad profitability rating. Also its financial health evaluation is rather negative. ALK is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALK has reported negative net income.

ALK had a positive operating cash flow in the past year.

Of the past 5 years ALK 4 years were profitable.

Each year in the past 5 years ALK had a positive operating cash flow.

1.2 Ratios

ALK's Return On Assets of -14.54% is on the low side compared to the rest of the industry. ALK is outperformed by 89.66% of its industry peers.

With a Return On Equity value of -46.87%, ALK is not doing good in the industry: 89.66% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-14.54%
ROE	-46.87%
ROIC	N/A

ROA(3y)-2.01%

ROA(5y)-0.01%

ROE(3y)-8.29%

ROE(5y)-1.48%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of ALK has declined.

ALK has a Gross Margin (53.53%) which is comparable to the rest of the industry.

ALK's Gross Margin has improved in the last couple of years.

ALK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	53.53%

OM growth 3Y-37.63%

OM growth 5Y-2.35%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.47%

GM growth 5Y7.25%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALK does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALK has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, ALK has more shares outstanding

The debt/assets ratio for ALK is higher compared to a year ago.

2.2 Solvency

ALK has an Altman-Z score of 1.76. This is a bad value and indicates that ALK is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of ALK (1.76) is worse than 68.97% of its industry peers.

ALK has a debt to FCF ratio of 6.79. This is a slightly negative value and a sign of low solvency as ALK would need 6.79 years to pay back of all of its debts.

ALK has a Debt to FCF ratio of 6.79. This is comparable to the rest of the industry: ALK outperforms 41.38% of its industry peers.

A Debt/Equity ratio of 0.44 indicates that ALK is not too dependend on debt financing.

ALK has a better Debt to Equity ratio (0.44) than 62.07% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.44
Debt/FCF	6.79
Altman-Z	1.76

ROIC/WACCN/A

WACC6.74%

2.3 Liquidity

ALK has a Current Ratio of 1.16. This is a normal value and indicates that ALK is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of ALK (1.16) is comparable to the rest of the industry.

ALK has a Quick Ratio of 1.16. This is a normal value and indicates that ALK is financially healthy and should not expect problems in meeting its short term obligations.

ALK has a Quick ratio (1.16) which is in line with its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.16
Quick Ratio	1.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -619.18%.

Looking at the last year, ALK shows a decrease in Revenue. The Revenue has decreased by -3.60% in the last year.

ALK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.61% yearly.

EPS 1Y (TTM)-619.18%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-445.2%

Revenue 1Y (TTM)-3.6%

Revenue growth 3Y6.02%

Revenue growth 5Y6.61%

Sales Q2Q%-1.68%

3.2 Future

ALK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 150.00% yearly.

Based on estimates for the next years, ALK will show a quite strong growth in Revenue. The Revenue will grow by 10.32% on average per year.

EPS Next Y478.57%

EPS Next 2Y150%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year14.75%

Revenue Next 2Y10.32%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 9.98, the valuation of ALK can be described as reasonable.

86.21% of the companies in the same industry are more expensive than ALK, based on the Price/Forward Earnings ratio.

Compared to an average S&P500 Price/Forward Earnings ratio of 37.13, ALK is valued rather cheaply.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.98

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as ALK.

		Industry Rank	Sector Rank
P/FCF	17.58
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as ALK's earnings are expected to grow with 150.00% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y150%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALK!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALKEMY SPA

BIT:ALK (7/9/2025, 7:00:00 PM)

+0.05 (+0.42%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryProfessional Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.14%

Inst Owner ChangeN/A

Ins Owners19.66%

Ins Owner ChangeN/A

Market Cap69.48M

Analysts45.71

Price Target10.91 (-9.08%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-5.73%

PT rev (3m)-5.73%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.98
P/S	0.62
P/FCF	17.58
P/OCF	9.59
P/B	2.07
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-2.85

EYN/A

EPS(NY)1.2

Fwd EY10.02%

FCF(TTM)0.68

FCFY5.69%

OCF(TTM)1.25

OCFY10.42%

SpS19.26

BVpS5.81

TBVpS-2.13

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.54%
ROE	-46.87%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	53.53%
FCFM	3.54%

ROA(3y)-2.01%

ROA(5y)-0.01%

ROE(3y)-8.29%

ROE(5y)-1.48%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)8.45%

ROCE(5y)8.95%

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-37.63%

OM growth 5Y-2.35%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.47%

GM growth 5Y7.25%

F-Score3

Asset Turnover1.03

Health

		Industry Rank	Sector Rank
Debt/Equity	0.44
Debt/FCF	6.79
Debt/EBITDA	N/A
Cap/Depr	74.51%
Cap/Sales	2.95%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.16
Quick Ratio	1.16
Altman-Z	1.76

F-Score3

WACC6.74%

ROIC/WACCN/A

Cap/Depr(3y)64.4%

Cap/Depr(5y)58.47%

Cap/Sales(3y)2.28%

Cap/Sales(5y)1.87%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-619.18%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-445.2%

EPS Next Y478.57%

EPS Next 2Y150%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-3.6%

Revenue growth 3Y6.02%

Revenue growth 5Y6.61%

Sales Q2Q%-1.68%

Revenue Next Year14.75%

Revenue Next 2Y10.32%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-236.16%

EBIT growth 3Y-33.87%

EBIT growth 5Y4.11%

EBIT Next Year318.23%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y7649.02%

FCF growth 3Y11.34%

FCF growth 5Y47.84%

OCF growth 1Y196.97%

OCF growth 3Y12.54%

OCF growth 5Y44.99%

ALKEMY SPA (ALK.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens